Skip to main content
Equibles
HALO $98.66 -2.00%
HALO logo

HALO · Halozyme Therapeutics, Inc.

Track HALO — free

Use HALO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about HALO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$98.66 -2.01 (-2.00%) At close · Aug 14
Market Cap
$11.20B
Shares
113.50M
All earnings calls

Earnings call · FY2019 Q4

Halozyme Therapeutics, Inc. Q4 FY2019 Earnings Call

Halozyme Therapeutics, Inc. Q4 FY2019 Earnings Call

Concluded Feb 24, 2020
Feb 24, 2020 0 turns
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $53.66M -10.9% YoY
Diluted EPS -$0.24
Gross margin 11.2% +2.8 pp YoY
Net income -$34.40M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 24, 2020 10-K report Filed Feb 24, 2020
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)